• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺/米力农与多巴胺/多巴酚丁胺治疗心源性休克的对比研究

[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].

作者信息

Meissner A, Schmelzle T, Simon R

机构信息

Klinik für Kardiologie, Christian-Albrechts-Universität Kiel.

出版信息

Z Kardiol. 1996 Nov;85(11):839-46.

PMID:9064946
Abstract

In cardiogenic shock, combined pharmacotherapy with dopamine/dobutamine was being used as a standard regimen and was compared to dopamine/milrinone in this study. In a total of 20 patients with persistent hemodynamic depression despite mechanical ventilation plus dopamine (10-12 micrograms/kg/min) and nitroglycerin (33 micrograms/min) infusions additional therapy with dobutamine (maximal dose: 9 micrograms/kg/min; n = 10) or milrinone (0.5 microgram/kg/min; n = 10) was started. Dobutamine induced an increase of cardiac index (2.0 +/- 0.1 to 2.9 +/- 0.21/min/m2; p < 0.01; mean +/- SEM) and heart rate (96 +/- 6 to 117 +/- 5 min-1; p < 0.05) while mean arterial pressure (75 +/- 2 to 71 +/- 4 mm Hg) and pulmonary capillary wedge pressure (21 +/- 2 to 19 +/- 2 mm Hg) hardly changed. The rate-pressure product rose from 10790 +/- 684 to 13234 +/- 678 mm Hg/ min (p < 0.05). Milrinone had a comparable effect on cardiac index (2.0 +/- 0.1 to 2.6 +/- 0.1 I/min/m2; p < 0.01) but induced a minor change in heart rate (94 +/- 6 to 104 +/- 8 min-1; p < 0.05) and a more pronounced decrease in mean arterial pressure (77 +/- 2 to 65 +/- 2 mm Hg; p < 0.01) and pulmonary capillary wedge pressure (24 +/- 2 to 17 +/- 1 mm Hg; p < 0.01). The rate-pressure product declined (11033 +/- 711 to 10555 +/- 929 mm Hg/min). In comparison, dopamine/milrinone appeared to be advantageous in terms of pre- and afterload reduction and myocardial oxygen demand. However, the concomitant decline in arterial pressure might impair end-organ perfusion.

摘要

在心源性休克中,多巴胺/多巴酚丁胺联合药物治疗被用作标准方案,在本研究中与多巴胺/米力农进行了比较。共有20例患者,尽管接受了机械通气、多巴胺(10 - 12微克/千克/分钟)和硝酸甘油(33微克/分钟)输注,但仍存在持续性血流动力学抑制,随后开始使用多巴酚丁胺(最大剂量:9微克/千克/分钟;n = 10)或米力农(0.5微克/千克/分钟;n = 10)进行额外治疗。多巴酚丁胺使心脏指数升高(从2.0±0.1升至2.9±0.2升/分钟/平方米;p < 0.01;平均值±标准误),心率升高(从96±6升至117±5次/分钟;p < 0.05),而平均动脉压(从75±2降至71±4毫米汞柱)和肺毛细血管楔压(从21±2降至19±2毫米汞柱)几乎没有变化。心率 - 血压乘积从10790±684升至13234±678毫米汞柱/分钟(p < 0.05)。米力农对心脏指数有类似作用(从2.0±0.1升至2.6±0.1升/分钟/平方米;p < 0.01),但引起心率的轻微变化(从94±6升至104±8次/分钟;p < 0.05),平均动脉压更明显下降(从77±2降至65±2毫米汞柱;p < 0.01),肺毛细血管楔压下降(从24±2降至17±1毫米汞柱;p < 0.01)。心率 - 血压乘积下降(从11033±711降至10555±929毫米汞柱/分钟)。相比之下,多巴胺/米力农在降低前负荷和后负荷以及心肌氧需求方面似乎更具优势。然而,动脉压的随之下降可能会损害终末器官灌注。

相似文献

1
[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].多巴胺/米力农与多巴胺/多巴酚丁胺治疗心源性休克的对比研究
Z Kardiol. 1996 Nov;85(11):839-46.
2
[Additive effects of milrinone and dobutamine in severe heart failure].米力农与多巴酚丁胺对重症心力衰竭的相加作用
Z Kardiol. 1992 May;81(5):266-71.
3
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.米力农和多巴酚丁胺用于严重心力衰竭:不同的血流动力学效应及个体患者反应性
Circulation. 1986 Mar;73(3 Pt 2):III175-83.
4
[Therapy of cardiogenic shock with dobutamine and nitroglycerin].[多巴酚丁胺与硝酸甘油治疗心源性休克]
Dtsch Med Wochenschr. 1983 Aug 26;108(34):1273-80. doi: 10.1055/s-2008-1069734.
5
Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone.当与米力农合用时,多巴胺可能比多巴酚丁胺能更好地维持心肌氧平衡。
Can J Anaesth. 2002 Nov;49(9):968-72. doi: 10.1007/BF03016885.
6
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].[多巴酚丁胺和米力农用于重度心力衰竭患者的血流动力学:个体内比较]
Z Kardiol. 1991 Feb;80(2):149-57.
7
[The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].[米力农联合多巴胺、多巴酚丁胺和/或硝普钠治疗难治性心力衰竭的血流动力学效应]
Rev Esp Cardiol. 1994 Oct;47(10):682-6.
8
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.米力农、多巴酚丁胺和硝普钠:对重度充血性心力衰竭患者血流动力学和心肌能量代谢的比较影响。
Circulation. 1986 Mar;73(3 Pt 2):III168-74.
9
[Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].[依诺昔酮与多巴胺联合治疗中的神经体液和血流动力学效应]
Z Kardiol. 1994;83 Suppl 2:37-48.
10
Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.自动输注硝酸甘油和硝普钠联合多巴酚丁胺在主动脉冠状动脉搭桥术后患者中增加心输出量的血流动力学等效性。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):602-7.

引用本文的文献

1
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.心源性休克中的血管活性药物治疗:一项批判性综述
J Drug Assess. 2021 Jul 20;10(1):68-85. doi: 10.1080/21556660.2021.1930548. eCollection 2021.
2
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.用于治疗心源性休克或低心排血量综合征的正性肌力药物和血管扩张剂策略。
Cochrane Database Syst Rev. 2020 Nov 5;11(11):CD009669. doi: 10.1002/14651858.CD009669.pub4.
3
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
用于治疗心源性休克或低心输出量综合征的正性肌力药物和血管扩张剂策略。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD009669. doi: 10.1002/14651858.CD009669.pub3.